Based on this finding we further examined the methylation of the PLA2R1 gene in tumor cell lines and in bone marrow aspirates of myelodysplastic syndrome (MDS) patients and compared the methylation of the PLA2R1 gene in the peripheral blood of leukemic patients with those of healthy control subjects. This evidence concerns the gene PLA2R1 and neoplasm.